Vanta Bioscience has received an order of Rs. 1.2 crore from a large Indian Multinational Company to carry out Technical Studies which includes oral toxicity study, Dermal Toxicity and in vitro tests and other studies. The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the Company for the project will be 5-24 weeks from receipt of requisite test items and/or such extended period as mutually agreed. Upon successful completion of the above, the Company is confident of receiving orders worth Rs. 12 crore approx. in next 2 financial years in one or more tranches from the said Company.Powered by Capital Market - Live News

Vanta Bioscience has received order of Rs 57 lakh from a renowned Singapore Company to carry out GLP Studies which includes Bacterial Reverse Mutation assay, oral toxicity study and in vitro tests and other studies. The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai. The turnaround time of the Company for the project will be 26 weeks from receipt of requisite test items and/or such extended period as mutually agreedPowered by Capital Market - Live News

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2023.Powered by Capital Market - Live News

Vanta Bioscience announced that the 7th Annual General Meeting (AGM) of the company will be held on 30 September 2023.Powered by Capital Market - Live News

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 10 August 2023.Powered by Capital Market - Live News